IPD Analytics
- Company typePrivate
- Founded2002
- HeadquartersAventura, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
IPD Analytics firmographics
Firmographics- Name
- IPD Analytics
- Legal name
- IPD Analytics, LLC
- Website
- https://ipdanalytics.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
IPD Analytics industry classification
Industry- Product category
- Pharmaceutical Market Intelligence
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)
- SIC
- Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- IP Due Diligence & Freedom-to-Operate (FTO) Analysis (BPAHAMAG)
Keywords
Where IPD Analytics is headquartered
LocationHeadquarters
- HQ city
- Aventura
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
IPD Analytics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Subscription-Based Platform Access: IPD Analytics offers subscription-based access to proprietary platforms providing comprehensive drug life-cycle analysis, payer and formulary management guidance, market access intelligence, clinical pipeline tracking, and other insights for healthcare decision-makers.
- Consultations: Direct consultations with IPD's expert team including clinical pharmacists, forecasters, and legal analysts available to subscribers.
- Email Alerts: Real-time email alerts delivering critical headlines, day-by-day trial updates, and key litigation updates to subscribers.
- Reports and Data Downloads: Comprehensive reports and data downloads including drug pipeline reports, market impact forecasts, and curated datasets available to subscribers.
- Podcast Content: IPD's Drug & Clinical Review podcast episodes featuring expert discussions on drug intelligence and management strategy.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Subscription-based access to proprietary platforms and insights |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
IPD Analytics product offering
Product offeringCore offering
IPD Analytics operates a subscription-based intelligence platform that identifies, projects, and quantifies the impact of competitive-landscape shifts in the pharmaceutical and biologic market. It aggregates data from thousands of sources, combines it with proprietary research, and delivers drug life-cycle analysis, loss-of-exclusivity timing, market impact forecasts, clinical pipeline tracking, formulary and reimbursement insights, and patent landscape intelligence through an online platform, email alerts, consultations, reports, data downloads, and podcasts.
Product overview
IPD Analytics operates as a subscription-based intelligence platform offering a comprehensive suite of pharmaceutical market analysis tools. The core platform consists of multiple integrated modules organized into four key capability areas: Life-Cycle Insights (including regional variants for U.S., Global, and 12 international markets covering Europe, Japan, Canada, Australia, Brazil, Mexico, India, Korea, Russia, China, Taiwan, and Saudi Arabia), Payer and Provider Insights (encompassing Access Hub, Payer & Provider Insights, Coding & Reimbursement, Budget Impact, and Primary Market Insights), Market and Financial Insights (including Market & Financial Insights, Rebate Monitor, and Portfolio and Formulation Insights), and Supporting Solutions (including Global Patent Search/GPS, Data STACK for curated datasets and visualizations, Legislation & Government Insights, Med-Tech Insights, and Product Liability Insights). The platform delivers insights through multiple formats including the online platform, email alerts, direct consultations, reports, podcast episodes, and data downloads. The company serves brand manufacturers, generic manufacturers, specialty drug manufacturers, active ingredient suppliers, payers, health systems, wholesalers, pharmacies, PBMs, GPOs, IDNs, institutional investors, and other pharmaceutical stakeholders.
Differentiator
Problem solved
Functional benefit
Products and services
- U.S. Life-Cycle Insights
Quantifiable outcome
- Analysis of 141 brand drugs across 40 manufacturers for patent exclusivity retention study
- +4 more outcomes
Companies that use IPD Analytics
Customer profileNamed customers7 records
Segments8 records
Ideal customer profiles5 records
IPD Analytics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature6 records
IPD Analytics partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Academy of Managed Care Pharmacy (AMCP)coreAMCP announced a strategic partnership with IPD Analytics in April 2026. Through this partnership, select AMCP staff will have access to IPD Analytics' platform and insights, which AMCP will use to inform resources developed for their members. This collaboration enhances understanding of market dynamics, formulary trends, pharmacy cost considerations, and key market catalysts, supporting informed decision-making across healthcare stakeholders.
- Institute for Clinical and Economic Review (ICER)minorIPD Analytics data is used by ICER as one of multiple drug pricing data sources (such as SSR Health, IPD Analytics, and Federal Supply Schedule) in their Launch Price and Access Report analyzing launch prices and patient access for new FDA-approved treatments. IPD's proprietary pricing data contributes to ICER's evidence-based reviews of healthcare interventions.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
IPD Analytics competitors and assessment
Company assessmentBroad incumbents
- GlobalData: GlobalData is a broader pharma and healthcare intelligence incumbent that overlaps IPD's pipeline, pricing, and market access coverage, offering a wider portfolio that competes for the same enterprise pharma intelligence budget.
- IQVIA: IQVIA is the dominant broad incumbent in pharma data, clinical, and commercial intelligence; it competes with IPD at the top end of enterprise pharma accounts, offering much broader data assets and global scale.
- Bloomberg Intelligence: Bloomberg Intelligence competes with IPD's Market & Financial Insights module, particularly for institutional investor and hedge fund subscribers seeking pharma forecasting and competitive landscape analysis.
Emerging players
- ZS Associates: ZS Associates competes with IPD in payer and provider market access analytics, with a heavier consulting overlay and overlapping pharma client base for value, access, and pricing strategy work.
Direct peers
- PatentSight (LexisNexis): PatentSight is a direct competitor in patent landscape analytics, directly overlapping IPD's Global Patent Search (GPS) and Paragraph IV / Orange Book analysis use cases for pharma IP teams.
- Norstella (Evaluate Pharma): Norstella's Evaluate franchise is a direct competitor to IPD Analytics in drug life-cycle forecasting, market impact analysis, and consensus sales forecasts for brand and generic drugs, serving a highly overlapping pharma manufacturer and investor customer base.
- Citeline (Pharma Intelligence, Informa): Citeline is a direct competitor covering drug pipeline intelligence, clinical trial tracking, and competitive landscape analysis — the same core use cases IPD serves through its Drug Pipeline and Life-Cycle Insights modules.
- Clarivate: Clarivate's Cortellis and IP-related products directly overlap IPD's Global Patent Search (GPS) and life-cycle insight offerings, competing for the same pharma IP and competitive intelligence budgets.
- DRG (Decision Resources Group): DRG competes with IPD in market access intelligence, payer/provider insights, and drug forecasting — a comparable subscription intelligence model targeting pharma and biotech commercial teams.
- SSR Health: SSR Health is a direct competitor specifically in drug pricing and rebate analytics — co-cited with IPD as a source by ICER in launch price and access reports.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
IPD Analytics social profiles
Digital presenceIPD Analytics compliance and trust
Trust signalCompliance1 record
IPD Analytics financial estimates
Financial estimateRevenue estimate
Valuation estimate
IPD Analytics leadership team
Management profileNumber of profiles
Profiles3 records
IPD Analytics subsidiaries and ownership
Company hierarchySubsidiaries1 record
IPD Analytics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IPD Analytics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IPD Analytics
What does IPD Analytics do?
IPD Analytics operates a subscription-based intelligence platform that identifies, projects, and quantifies the impact of competitive-landscape shifts in the pharmaceutical and biologic market. It aggregates data from thousands of sources, combines it with proprietary research, and delivers drug life-cycle analysis, loss-of-exclusivity timing, market impact forecasts, clinical pipeline tracking, formulary and reimbursement insights, and patent landscape intelligence through an online platform, email alerts, consultations, reports, data downloads, and podcasts.
Is IPD Analytics a public or private company?
IPD Analytics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was IPD Analytics founded?
IPD Analytics was founded in 2002. It employs 51 to 100 people.
Where is IPD Analytics based?
IPD Analytics is headquartered in Aventura, United States, in the North America region.
How does IPD Analytics make money?
Five revenue lines are on record. Subscription-Based Platform Access are the primary driver. The others are consultations, email Alerts, reports and Data Downloads and podcast Content.
Who are IPD Analytics's main competitors?
Broad incumbents on record are GlobalData, IQVIA and Bloomberg Intelligence. ZS Associates is listed as an emerging player. Direct peers are PatentSight (LexisNexis), Norstella (Evaluate Pharma), Citeline (Pharma Intelligence, Informa), Clarivate, DRG (Decision Resources Group) and SSR Health.
Does IPD Analytics have an API?
No public API is recorded for IPD Analytics.
What industry is IPD Analytics in?
IPD Analytics's product category is Pharmaceutical Market Intelligence. Its primary akta.pro industry code is BPAHAMAG, IP Due Diligence & Freedom-to-Operate (FTO) Analysis. Its NAICS code is 5182 and its SIC code is 7373.